文献速递白内障与屈光手术青光眼

白内障手术降低高眼压治疗研究药物组眼压及用药

Cataract Surgery Lowers Intraocular Pressure and Medication Use in the Medication Group of the Ocular Hypertension Treatment Study.
PubMed 文献 · Am J Ophthalmol · 2021-07-17

该研究为随机临床试验数据的二次分析,纳入高眼压治疗研究药物组中92例(149眼)接受白内障手术者与531例(1004眼)未手术者,比较术后72个月内眼压和降眼压药物种类变化;白内障手术使术后降眼压药物种类持续减少,眼压下降但差异12个月后不再显著。

要点

  • 白内障手术使高眼压患者术后降眼压药物种类持续减少至术后48个月。
  • 术后眼压下降,但组间眼压差异12个月后不再显著。
  • 约23%术眼在分界点无用药,41%用药负担减轻。

核心结论

  • 高眼压患者行白内障手术可持久减少平均降眼压药物种类,并短暂降低眼压。

研究设计与样本

  • 随机临床试验数据的二次分析,纳入药物组92例(149眼)接受白内障手术者与531例(1004眼)未手术者,设分界点后比较72个月内指标。

主要发现

  • 与对照组相比,白内障手术组在所有术后随访点降眼压药物种类显著减少(平均-0.4种,P≤.005),持续至术后48个月。
  • 分界点时约23%术眼无用药,41%术眼用药负担减轻。
  • 白内障手术导致眼压下降(P<.001),但组间眼压差异随时间缩小,12个月后不再显著。

关键数值与推荐

  • 降眼压药物种类平均减少0.4种(P≤.005),持续至术后48个月。
  • 眼压下降P<.001,但组间差异12个月后无统计学意义。
  • 分界点时23%术眼无用药,41%用药负担减轻。

临床怎么用

  • 高眼压患者白内障术后可考虑减少降眼压药物种类,但需注意眼压获益可能短暂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To determine the change in intraocular pressure (IOP) and ocular hypotensive medication use after cataract extraction in the Medication Group of the Ocular Hypertension Treatment Study. DESIGN: Secondary analysis of randomized clinical trial data. METHODS: We included 92 participants (n = 149 eyes) of the Medication Group of the Ocular Hypertension Treatment Study who underwent cataract surgery in at least 1 eye during the study and 531 participants (n = 1004 eyes) of the Medication Group who did not undergo cataract surgery. We defined the "split date" as the first study visit that cataract surgery was reported for the cataract surgery group and the 15th visit in the control group to equalize the median number of visits. We then compared the 2 groups at visits relative to this split date. MAIN OUTCOME MEASURES: Difference in preoperative and postoperative IOP, and number of classes of ocular hypotensive medications between the cataract and control group over a 72-month period. RESULTS: Cataract surgery significantly decreased the number of ocular hypotensive medications at all postoperative visits (mean, -0.4 medications; P ≤ .005) through the 48-month postoperative visit when compared with the control group. At the split date, approximately 23% of eyes were medication free and 41% had a reduced medication burden. Cataract surgery resulted in a decrease in IOP (P < .001), but the difference in IOP between the groups reduced over time and became nonsignificant after 12 months. CONCLUSIONS: Cataract surgery in patients with ocular hypertension produced sustained reductions in the average number of ocular hypotensive medications and transient reductions in IOP.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Mansberger SL, Gardiner SK, Gordon M, et al. Cataract Surgery Lowers Intraocular Pressure and Medication Use in the Medication Group of the Ocular Hypertension Treatment Study. Am J Ophthalmol. 2021. PMID: 34280363. doi:10.1016/j.ajo.2021.07.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。